Stocks · News reference
Teladoc Health shares slid in Thursday's premarket after Q2 results and a cautious outlook tempered its earnings outlook.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-03 AccNo: 0001477449-26-000040 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarCitigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.
Read original at benzingaMarkets recovered from yesterday's losses with the Nasdaq up 2.42% as technology stocks rallied. Microsoft surged 15.5% following strong earnings results, boosting investor confidence in AI spending. However, GDP growth slowed to 1.5% in Q2, below expectations, signaling underlying economic uncertainty despite the market rebound.
Read original at the-motley-fool